SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corporation

Applied Digital is experiencing intense volatility as investors weigh the stock's long-term potential in the data center and AI infrastructure sector against macro-driven sell-offs linked to geopolitical tensions and debt concerns. While the community remains divided between those panic-selling and those adding to their positions ahead of upcoming earnings, sentiment is heavily focused on the anticipation of new hyperscaler lease announcements that could serve as a major catalyst for a price recovery.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing significant volatility as investors weigh the company's shift toward high-performance AI data center infrastructure against macro-driven sell-offs and geopolitical instability in the Middle East. While community sentiment remains polarized, many participants are focused on the company's execution timeline for new site energization and the potential for major hyperscaler contract announcements to serve as a catalyst for recovery.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is facing intense community debate as investors weigh concerns over potential dilution and future stock splits against optimism surrounding the commercial traction and insurance coverage expansion of their lead product, Tonmya. While some shareholders are selling amid downward price pressure and a history of capital raises, others are aggressively buying the dip, citing strong long-term pipeline fundamentals and recent insider share purchases as evidence of an impending turnaround.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is seeing heightened market attention as traders closely monitor the expected finalization of a multi-billion dollar debt financing deal, which is widely viewed as a critical catalyst for the firm's data center expansion. The stock's recent volatility has sparked intense debate among community members, who are actively balancing concerns over insider selling and high debt levels against the company's strategic partnerships and potential upside in the evolving AI infrastructure sector.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy Corp

Bloom Energy is currently rallying as investors position the stock as a primary 'bring-your-own-power' solution for the surging AI data center buildout, further fueled by recent policy discussions surrounding energy infrastructure independence. The community is actively debating the stock's valuation and volatility, while tracking technical breakout levels and watching for institutional accumulation as the company solidifies its role in the critical power generation sector.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is experiencing intense volatility as investors debate the impact of its newly announced five-for-one stock split, with many in the community viewing the move as a tactic to boost retail liquidity and obscure ongoing concerns regarding subprime loan exposure. The stock remains a battleground for traders, with heavy debate over potential technical breakdowns versus institutional efforts to defend key price levels.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is capturing significant market attention following positive long-term Phase 3 VELA data, with investors increasingly focused on the stock's potential as a best-in-class candidate in the competitive immunology space. While some retail shareholders express frustration over recent volatility and perceived market manipulation, community sentiment remains largely driven by anticipation of upcoming 52-week data readouts and persistent speculation regarding a potential buyout from major biopharma players.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

Fannie Mae ($FNMA) is seeing intense trading activity as investors react to ongoing speculation about an exit from conservatorship, with prominent figures like Bill Ackman and Michael Burry reportedly maintaining long positions. Community sentiment remains deeply divided, with bulls pointing to potential future catalysts and institutional buying, while bears emphasize the lack of concrete news and the stock's recent volatility.

Pelican Acquisition Corporation is a special-purpose acquisition company that aims to merge with or acquire businesses, particularly in the global technology sector. The company's primary purpose of facilitate a merger, share exchange, asset acquisition, share purchase, reorganization, or any other form of business combination with one or more businesses.

Greenland Energy Co.

Greenland Energy is capturing significant market attention following its recent NASDAQ debut and business combination, as traders speculate on the potential for massive oil reserves in the Jameson Land Basin. The community is actively debating the company's long-term exploration goals versus short-term volatility, with many monitoring volume, potential squeezes, and the involvement of experienced industry leadership.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

Semiconductors are currently the subject of intense debate as the sector balances extreme investor enthusiasm for AI-driven infrastructure against mounting fears of a parabolic bubble and cyclical overextension. Market participants are actively weighing record project backlogs and bullish sentiment against rising concerns regarding long-term ROI, high capital expenditure, and the potential for a sharp mean reversion that could pressure broader market indices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS some people keep talking about Shrkeli being short SLS.  Maybe.  He sure talked it down when it was like $1 per share and ever since then it is up up up - like 6x.  His primary arguments were extremely flawed: WT1 is a bad target, GPS probably doesn&#39;t work (based on nothing at all), and the 60 event interim look did not result in any action at all.  Well...we all know that GPS must work because the pooled results are so good there is no other explanation.  The math is pretty clear.  I would be pretty surprised if any smart people are short at this point.

Margaret (Peggy) Murphy

Knut Kraut

Jeremy Dworkin

Ferdinand Baudet

ming yu

Dingus McKringleberry

nick

Stephen

Bill Day

$SLS stop talking about him. Hes not even short sls he just spouts nonsense about it failing and has been for years. Hes never said hes short sls

StockTwits For Android 

YEHMINGZHU

StockTwits Web

SELLAS Life Sciences Group Inc

 some people keep talking about Shrkeli being short SLS.  Maybe.  He sure talked it down when it was like $1 per share and ever since then it is up up up - like 6x.  His primary arguments were extremely flawed: WT1 is a bad target, GPS probably doesn't work (based on nothing at all), and the 60 event interim look did not result in any action at all.  Well...we all know that GPS must work because the pooled results are so good there is no other explanation.  The math is pretty clear.  I would be pretty surprised if any smart people are short at this point.

Merck & Co Inc

Anavex Life Sciences Corp

Verona Pharma Plc American Depositary

Annovis Bio Inc

Nurix Therapeutics Inc

Terns Pharmaceuticals Inc

Upstream Bio Inc.

stjernerogvann

@stjernerogvann did that dude even participate in this process? Didn&#39;t he just buy patents and price gouge? I don&#39;t know why I&#39;m listening to this guy and not my barber.

 did that dude even participate in this process? Didn't he just buy patents and price gouge? I don't know why I'm listening to this guy and not my barber.

Candel Therapeutics Inc

Jon Brandon

@Brandonswest he is smart but comes at things from a predictable and pre-formed opinion angle.  His blind spots have resulted in investment losses and jail time.  Not someone I would depend on for advice.

 he is smart but comes at things from a predictable and pre-formed opinion angle.  His blind spots have resulted in investment losses and jail time.  Not someone I would depend on for advice.

@stjernerogvann What his theory &#39;probably&#39; also banking on is that there are more deaths than reported. He thinks that the company though not under counting events is looking at ways to push reporting out by  months on some pretext or the other. The guy is a freak show. He cannot answer a whole lot of legit questions but gets stuck on his own dumb record in his head.

 What his theory 'probably' also banking on is that there are more deaths than reported. He thinks that the company though not under counting events is looking at ways to push reporting out by  months on some pretext or the other. The guy is a freak show. He cannot answer a whole lot of legit questions but gets stuck on his own dumb record in his head.

Micron Technology Inc

Altimmune Inc

Cemtrex Inc.

Opendoor Technologies Inc

Strive Inc.

Galaxy Digital Inc. - Ordinary Shares - Class A

Anand

@stjernerogvann I think Shrkeli is paid by the shorts.

Cel-Sci Corp

Lexicon Pharmaceuticals Inc

Sangamo Therapeutics Inc

Royal Caribbean Group

Norwegian Cruise Line Holdings Ltd

Soligenix Inc

Anonymous10000

@stjernerogvann That a-hole bad mouthed CAPR for months and cost his followers Millions of dollars by telling them to short it...horrible call!!  Even admitted it which had to be hard for him,..being the most egotistical idiot I&#39;ve ever seen on here!!

 That a-hole bad mouthed CAPR for months and cost his followers Millions of dollars by telling them to short it...horrible call!!  Even admitted it which had to be hard for him,..being the most egotistical idiot I've ever seen on here!!

Capricor Therapeutics Inc

Scott Chittum

@Search_2312 the clinics involved in this trial are extremely reputable (UCLA, MD Anderson, Swedish) so the notion that there are unknown deaths or data is pretty far-fetched.

 the clinics involved in this trial are extremely reputable (UCLA, MD Anderson, Swedish) so the notion that there are unknown deaths or data is pretty far-fetched.

@stjernerogvann do not disagree. Not about the hospitals per se.

 do not disagree. Not about the hospitals per se.